A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Northwell Health, Great Neck

State University of New York Upstate Medical Center (SUNY), Syracuse

University of North Carolina at Chapel Hill, Chapel Hill

North Georgia Rheumatology Group-Duluth, Lawrenceville

Millennium Research, Ormond Beach

CRIA Research, Fort Lauderdale

Clinical Research of West Florida - Clearwater, Clearwater

University of Alabama at Birmingham, Birmingham

Pinnacle Research Group, LLC, Anniston

Oklahoma Medical Research Foundation, Oklahoma City

Southwest Rheumatology Research, LLC, Mesquite

Accurate Clinical Research, Houston

University of Colorado Denver, Aurora

Institute of Arthritis Research, Idaho Falls

University of California San Diego, La Jolla

ACRC Studies, Poway

Arthritis Northwest Rheumatology, Spokane

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston